Ablation therapy for Barrett's esophagus

Gastrointestinal Endoscopy

Volumn 58, Issue 5, 2003, Pages 760-769

  Eisen, Glenn M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER RISK; CATHETER ABLATION; DISEASE COURSE; DYSPLASIA; ELECTROCOAGULATION; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; NEODYMIUM LASER; OBESITY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

BARRETT ESOPHAGUS; CATHETER ABLATION; FOLLOW-UP STUDIES; HUMANS; TREATMENT OUTCOME;

EID: 0242626017     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(03)02002-9     Document Type: Review

References (70)

1. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26(5 Suppl 15):2-8.
2. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
3. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90.
4. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
5. Phillips RW, Wong RKH. Barrett's esophagus: natural history, incidence, etiology and complications. Gastroenterol Clin North Am 1991;20:791-816.
6. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
7. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002;123:461-7.
8. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670-80.
9. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-8.
10. Gore S, Healey CJ, Sutton R, Eyae-Brook IA, Gear MW, Shepherd NA, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
11. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990;35:93-6.
12. Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997;92:582-5.
13. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low-high risk patients subsets. Am J Gastroenterol 2000;95:1669-76.
14. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term non-surgical management of Barrett's esophagus with high grade dysplasia. Gastroenterology 2001;120:1607-19.
15. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992;54: 199-204.
16. Rice TW, Falk GW, Achar E, Petras RE. Surgical management of high grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-6.
17. Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK, et al. Esophageal cancer: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 2000;190:548-59.
18. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high grade dysplasia. Ann Surg 1996;224:66-71.
19. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
20. Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS. Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993;38:365-8.
21. Lin OS, Mannava S, Hwang K-L, Triadafilopoulos G. Reasons for current practices in managing Barrett's esophagus. Dis Esophagus 2002;15:39-45.
22. Sampliner R. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
23. Montes CG, Brandalise NA, Deliza R, Novais de Magalhaes AF, Ferraz JG. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 1999;50:173-7.
24. Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997;92:582-5.
25. Kovacs BJ, Chen YK, Lewis TD, DeGuzman LJ, Thompson JS. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc 1999;49:547-53.
26. Micholpoulos S, Tsibouris P, Bouzakis H, Sotiropoulou M, Kralios N. Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results. Gastrointest Endosc 1999;50:165-72.
27. Sampliner RE, Faigel D, Fennerty MB, Lieberman D, Ippoliti A, Lewin K, et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 2001;53:554-8.
28. Fennerty MB, Corless CL, Sheppard B, Faigel DO, Lieberman DA, Sampliner RE. Pathologic documentation of complete elimination of Barrett's metaplasia following multipolar electrocoagulation therapy. Gut 2001;49:142-4.
29. Norberto L, Ranzato R, Marino S, Angriman I, Errol F, Donadi M, et al. Endoscopic palliation of esophageal and cardinal cancer: neodymium-yttrium aluminum garnet laser therapy. Dis Esophagus 1999;12:294-6.
30. Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS. Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993;38:365-8.
31. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993;104:1686-91.
32. Van den Bogert J, van Hillegersberg R, Siersema PD, de Bruin RWF, Tilanus HW. Endoscopic ablation for Barrett's esophagus with high grade dysplasia: a review. Am J Gastroenterol 1999;94:1153-60.
33. Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 1999;49:8-12.
34. Salo JA, Salminen JT, Kiviluoto TA, Nemlander AT, Ramo OJ, Farkkila M, et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 1998;227:621-3.
35. Bonavina L, Ceriani C, Carrazzone A, Segalin A, Ferrero S, Peracchia A. Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile? J Gastrointest Surg 1999;3:194-9.
36. Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histologic evidence of squamous re-epithelialisation. Gut 1997;41:281-4.
37. Luman W, Lessels Am Palmer KR. Failure of Nd - YAG photocoagulation therapy as treatment for Barrett's esophagus: a pilot study. Eur J Gastroenterol Hepatol 1996;8:627-30.
38. Weston AP, Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 2002;97:2998-3006.
39. Ginsberg GG, Barkun AN, Bosco JJ, Burdick JS, Isenberg GA, Nakao NL. The argon plasma coagulator. Gastrointest Endosc 2002;55:807-10.
40. Tigges H, Fuchs KH, Maroske J, Fein M, Freys S, Muller J. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J Gastrointest Surg 2001;5:251-9.
41. Basu KK, Pick B, Bale R, West KP, deCaestecker JS. Efficacy and one year follow-up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 2002;51:776-80.
42. Morino M, Rebecchi F, Giaccone C, Taraglio S, Sidoli L, Ferraris R. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication. Surg Endosc 2003;17:539-42.
43. Schulz H, Miehlke S, Antos D, Schenyke KU, Vieth M, Stolte M, et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high dose omeprazole. Gastrointest Endosc 2000;51:659-63.
44. Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998;93:1810-5.
45. Mork H, Barth T, Kreipe HH, Kraus M, Al-taie O, Jakob F. Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study. Scand J Gastroenterol 1998;33:1130-4.
46. Van Laethem JL, Cremer M, Peny MO, Delhaye M, Deviere J. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and long-term results. Gut 1998;43:747-51.
47. Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 2000;95:1661-8.
48. Grade AJ, Shah IA, Medlin SM, Ramirez FC. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc 1999;50:18-22.
49. Van Laethem JL, Jagodzinski R, Peny MO, Cremer M, Deviere J. Argon plasma coagulation in the treatment of Barrett's high grade dysplasia and in situ adenocarcinoma. Endoscopy 2001;33:257-61.
50. May A, Gossner L, Gunter E, Stolte M, Ell C. Local treatment of early cancer in short Barrett's esophagus by means of argon plasma coagulation: initial experience. Endoscopy 1999;31:497-500.
51. Van Laethem JL, Peny MO, Salmon I, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000;46:574-7.
52. Kelty CJ, Marcus SL, Ackroyd R. Photodynamic therapy for Barrett's esophagus: a review. Dis Esophagus 2002;15:137-44.
53. Gossner L, Stolte M, Sroka R, Rick K, et al. Photodynamic ablation of high grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-55.
54. Panjehpour M, Overholt BF, DeNovo RC, Sneed RE, Petersen MG. Centering balloon to improve esophageal photodynamic therapy. Lasers Surg Med 1992;12:631-8.
55. Barr H, Shepard NA, Dix A, Roberts DJ, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584-5.
56. Wang KK. Photodynamic therapy of Barrett's esophagus. Gastrointest Endosc Clin N Am 2000;10:409-19.
57. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7.
58. Ortner MA, Zumbusch KL, Ebert B, Fleige B, Dietel M, Lochs H. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. Endoscopy 2002;34:611-6.
59. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 2002;77:1176-81.
60. Johnston MH, Schoenfeld P, Mysore JV, Dubois A. Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastrointest Endosc 1999;50: 86-92.
61. Rodgers BM, McDonlad AP, Talbert JL, Donnelly WH. Morphologic and functional effects of esophageal cryotherpay. J Thorac Cardiovasc Surg 1979;77:543-9.
62. Ackroyd R, Brown NJ, Davis MF, Stephenson TJ, Marcus SL, Stoddard CJ, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomized, placebo controlled trial. Gut 2000;47:612-7.
63. Overholt BF, Haggitt RC, Bronner MP, Taylor SL, Hao Y, Colin P, et al. A multicenter, partially blinded randomized study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): results of 6-month follow-up [abstract]. Gastroenterology 2001;120:A79.
64. Kahaleh M, Van Laethem JL, Nagy N, Cremer M, Deviere J. Long-term follow-up and factors predictive of recurrence of Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 2002;34:950-5.
65. Sharma P, Jaffe PE, Bhattacharyya A, Sampliner RE. Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up. Gastrointest Endosc 1999;49:442-6.
66. Gross CP, Cruz-Correa M, Canto MI, McNeil-Solis C, Valente TW, Powe NR. The adoption of ablation therapy for Barrett's esophagus: a cohort study of gastroenterologists. Am J Gastroenterol 2002;97:279-86.
67. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000;52:197-203.
68. Krishnadath KK, Wang KK, Taniguchi K, Sebo TJ, Buttar NS, Anderson MA, Lutzke LS, Liu W. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000;119:624-30.
69. Sampliner RE, Camargo L, Fass R. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Am J Gastroenterol 2002;97:270-2.
70. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high risk patient subsets. Am J Gastroenterol 2000;95:1669-76.